You are here

  • Home
  • Archive
  • Volume 82, Issue 12
  • Correspondence on ‘NCF1-339 polymorphism is associated with altered formation of neutrophil extracellular traps, high serum interferon activity and antiphospholipid syndrome in systemic lupus erythematosus’ by Linge et al

Article info

Article menu

Download PDFPDF

Correspondence
Correspondence on ‘NCF1-339 polymorphism is associated with altered formation of neutrophil extracellular traps, high serum interferon activity and antiphospholipid syndrome in systemic lupus erythematosus’ by Linge et al
Free

Authors

  • George N Goulielmos Section of Molecular Pathology and Human Genetics, Department of Internal Medicine, School of Medicine, University of Crete, Heraklion, Greece Department of Internal Medicine, University Hospital of Heraklion, Heraklion, Greece PubMed articlesGoogle scholar articles
  • Maria I Zervou Section of Molecular Pathology and Human Genetics, Department of Internal Medicine, School of Medicine, University of Crete, Heraklion, Greece PubMed articlesGoogle scholar articles
  • Elias Eliopoulos Laboratory of Genetics, Department of Biotechnology, Agricultural University of Athens, Athens, Greece PubMed articlesGoogle scholar articles
  1. Correspondence to Dr George N Goulielmos, Section of Molecular Pathology and Human Genetics, Department of Internal Medicine, School of Medicine, University of Crete, Heraklion 74100, Greece; goulielmos{at}med.uoc.gr
View Full Text

Citation

Goulielmos GN, Zervou MI, Eliopoulos E
Correspondence on ‘NCF1-339 polymorphism is associated with altered formation of neutrophil extracellular traps, high serum interferon activity and antiphospholipid syndrome in systemic lupus erythematosus’ by Linge et al
Annals of the Rheumatic Diseases 2023;82:e231.

Publication history

  • Received November 17, 2021
  • Accepted November 18, 2021
  • First published January 17, 2022.
Online issue publication 
November 22, 2023

Article Versions

Copyright information

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.